A method and apparatus for providing microcurrent stimulation (MSC)
therapy. In accordance with the present invention, it has been determined
that the application of microcurrent signals at particular frequencies to
the eye for particular periods of time stabilizes and even improves
conditions of macular degeneration and other ocular diseases.
Experimental data from clinical trials shows that results of persons who
underwent therapy are at least better than placebo, and that the therapy
is safe and efficacious. In fact, experimental data from clinical trials
showed that approximately 98% of the patients who underwent the MCS
therapy of the invention experienced either stabilization or improvement
of macular degeneration within one year of starting therapy. Of this
percentage, approximately 65% of the patients subjected to the MCS
therapy experienced improved vision, while approximately 32% experienced
stabilization of macular degeneration (i.e., no further loss of vision).
